Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 1,505 shares at $32.75 ($50K) on 2014-08-01, disclosed to the SEC on 2014-08-04.
Scheduled sale ($50k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.75 | 1,290 | $42K | 84.9% |
| 2 | $35.00 | 215 | $8K | 15.1% |
| Total | $33.07 avg | 1,505 | $50K | 100% |
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |